Shreevatsaa Finance and Leasing Limited

Financial Services — Financial Conglomerates · BSE

₹27.37₹0.00 (0.00%)

DalalBaazaar Score

63 / 100

🟢 Good

Verdict

NEUTRAL

Risk

Moderate

Driven by negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:09 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Shreevatsaa Finance and Leasing Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Shreevatsaa Finance and Leasing Limited operates as a non-banking finance company in India. The company operates through the Trading Activity and Financing activity segments. It engages in the business of loans and advances; investment; trading in stocks; and mutual fund units.

IndustryFinancial Conglomerates

SectorFinancial Services

Employees5

Annual revenue₹1 Cr

How does it make money?

Turns over ₹1 Cr a year. Of every ₹100 of sales, about ₹35 reaches shareholders as profit, with ₹50 left at the operating level before interest, tax and depreciation. Each of its 5 employees supports ₹19.0 lakh of revenue a year, the signature of a people-led business.

EBITDA margin49.8%

Net margin35.2%

Revenue / employee₹19.0 lakh

Who are its competitors?

The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, HDFC BANK LTD, ICICI BANK LTD., STATE BANK OF INDIA. These are the companies its valuation and returns are measured against elsewhere in this report.

BAJAJ FINANCE LIMITEDP/E 30.2x · ROE 17.8%

HDFC BANK LTDP/E 15.9x · ROE 13.8%

ICICI BANK LTD.P/E 18.1x · ROE 16.5%

STATE BANK OF INDIAP/E 10.3x · ROE 15.2%

What is its competitive advantage?Not assessable from these ratios

For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.

ROCE2.0%

ROE1.4%

Peer median ROE16.5%

What has been driving growth?

Sales and margins have both contributed to where profit is now. Over 3 years revenue moved +18% while net margin moved -15% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+18%

Margin effect-15%

DalalBaazaar Score

63/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Revenue CAGR of only 5.6% — barely ahead of inflation
✗ Profit has declined at 0.2% a year
✗ Profit is compounding slower than revenue — margins are being squeezed as the business grows

Quality vs. Valuation

Company Quality

63/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

47/ 100

Fair

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

48.0x

3Y Median

64.1x

40 monthly readings · mean 64.4x · range 41.4x–94.3x

Sector Median

17.0x

median of 4 sector peers

🟢Current valuation is approximately 25% below its 3y median of 64.1x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

⚠️Against its sector it trades 183% above the peer median of 17.0x.

vs. its own history

Cheap

64.1x median over 40 months · -25%

vs. sector peers

Expensive

17.0x median of 4 peers · +183%

vs. generic bands

Expensive

Above 35x

P/E (Trailing)

48.0x

P/B

1.22x

EV/EBITDA

58.1x

PEG

—

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well2

Valuation below its historical average
At 48.0x the stock trades 25% below its own median of 64.1x.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention1

Margins are compressing
EBITDA margin has slipped from 57.8% to 49.8% over 3 years.

Red Flags

1 item require attention · 1 high

🔴Significant margin compressionFinancial
EBITDA margin has fallen 8.0 points, from 57.8% to 49.8%.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 25% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 57.8% to 49.8%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
A premium to the sector to defend
It trades 183% above the peer median. That premium needs a reason that persists, or it closes.
Growth barely outpaces inflation
Revenue compounding at 5.6% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 48%✓ 49.8%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Return on equity stays above 8%✗ 1.4%
For a lender this is the cleanest single read on whether the book is being grown profitably.
3Revenue growth stays above 4% a year✓ 5.6% CAGR
Latest reported year was 44.1%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
4Valuation vs its own median of 64.1x✓ 48.0x today
A re-rating above its own history needs a reason; without one it is just a higher price.

Investment Checklist

6 / 10 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✗ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

4 good · 3 neutral · 4 weak

Market Cap

₹28 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

48.0x

Expensive

Expensive — verify against sector peers

P/B Ratio

1.22x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹0.57

Profitable

Profitable on a per-share basis

ROE

1.4%

Weak

Weak capital efficiency

ROCE

2.0%

Weak

Low return on total capital employed

Debt/Equity

Not available

No data

Source didn't return this field

Revenue Growth (YoY)

44.1%

Healthy

Healthy top-line growth

Profit Growth (YoY)

81.8%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹0 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹27.37

Operating Margin

60.5%

Good

Healthy core-business profitability

Net Margin

40.2%

Good

Strong bottom-line conversion

Current Ratio

1.96

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.16

Defensive

Steadier than the market

52W Range Position

26%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

26.8 / 25.2

Bullish alignment (short > long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

60.9

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	+5.6%
EBITDA	₹0 Cr	₹1 Cr	₹1 Cr	₹0 Cr	+0.5%
EBITDA Margin	57.8%	66.9%	60.3%	49.8%	—
PAT (Net Profit)	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	-0.2%
EPS	₹0.33	₹0.38	₹0.45	₹0.33	+0.0%
ROE	1.5%	1.7%	2.0%	1.4%	—
ROCE	2.1%	2.6%	2.4%	2.0%	—
Free Cash Flow	₹3 Cr	₹0 Cr	-₹0 Cr	-₹0 Cr	—

🟢 Revenue has grown at 5.6% a year over 3 years.

🟡 EBITDA has been broadly flat over 3 years (0.5% a year).

🔴 EBITDA Margin has fallen from 57.8% to 49.8% over 3 years (-8.0 pts).

🟡 PAT (Net Profit) has been broadly flat over 3 years (-0.2% a year).

🟡 EPS has been broadly flat over 3 years (0.0% a year).

🟡 ROE has held roughly flat at 1.4% over 3 years.

🟡 ROCE has held roughly flat at 2.0% over 3 years.

🔴 Free Cash Flow has turned negative, from ₹3 Cr to -₹0 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹23 Cr

Total Liabilities

₹0 Cr

Total Debt

—

Cash & Equivalents

₹0 Cr

Operating Cash Flow

-₹0 Cr

Capex

—

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

90.0%

Peer Comparison

Company	P/E	ROE
BAJAJ FINANCE LIMITED	30.2x	17.8%
HDFC BANK LTD	15.9x	13.8%
ICICI BANK LTD.	18.1x	16.5%
STATE BANK OF INDIA	10.3x	15.2%

Recent News

1 positive3 mixed2 general

Shreevatsaa Finance submits voting results for 40th AGM held on Sep 24

scanx.trade, 24 SeptResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Invigorated Business Consulting Ltd. (INVIGO) Share Price Surges 8.33% Today

Univest, 28 JulPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Swasti Vinayaka Art & Heritage Corporation standalone net profit rises 189.47% in the March 2026 quarter

Business Standard, 01 JunResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

15 Cement Stocks In Focus Ahead Of Q1 Results; Ambuja, UltraTech Among 'Buy', Ramco Rated 'Reduce'— Full List Inside

NDTV Profit, 13 JulResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

JMJFIN Stock Price and Chart — BSE:JMJFIN

TradingView, 07 Oct

Jindal Capital (BSE:530405) - Stock Analysis

Simply Wall Street, 01 Dec

Watch Items

This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
1 metric couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.

DalalBaazaar Thesis

🟢Business QualityStrong15.9/20

🟢Financial HealthStrong17/20

🔴GrowthWeak5.7/20

🟡ProfitabilityModerate8.9/15

🟡ValuationFair9.7/15

🟡RiskModerate5.4/10

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 1 high-severity red flag sits above this conclusion and should be read first.

This thesis breaks if

✓EBITDA margin holds above 48%49.8%
✗Return on equity stays above 8%1.4%
✓Revenue growth stays above 4% a year5.6% CAGR
✓Valuation vs its own median of 64.1x48.0x today